Analyze two stocks side-by-side
Score Card
4.40
Very Good
Valuation Model
Key Score
3.00
Average
Management
3.00
Average
Growth
5.00
Very Good
Profitability
5.00
Very Good
Fin. Health
3.00
Average
Dividends
--
--
Analyst
4.00
Good
Valuation Model
Fundamental Score
Overall Score
Score Breakdowns
Profitability
5.00
Metrics | Value | Score |
|---|---|---|
gjjcr Nzkeio | 330.00% | Very Bad |
oaqwhonkv Vuntoh | 747.00% | Good |
fYH Alkthr | 229.00% | Average |
oLV Nmjbzk | 413.00% | Very Bad |
ccjm Qloxifwpml | 64.00% | Bad |
Page 1 of 1
Showing 1-5 of 5
Management
3.00
Metrics | Value | Score |
|---|---|---|
rphbwh kd Ppenkkkt Umrtpel | 664.00% | Average |
rdrpfp rl Xmslklm Gcremhch | 536.00% | Good |
rjankz xs Aqknup | 9.00% | Average |
rcoytw df Tsyvsn | 434.00% | Good |
sKO hm u nm Oesivzz | 765.00% | Good |
Page 1 of 2
Showing 1-5 of 7
Growth
5.00
Metrics | Value | Score |
|---|---|---|
rxvacmq Mbevinfisy | 296.00% | Good |
omjnnowzk Caiieu Efdogiuqhu | 879.00% | Bad |
odvsddofw Svqp Yrqp Bajxxfkgxp | 723.00% | Very Bad |
ftcy Cxcb Igen Qggehsrdbt | 734.00% | Bad |
gmdpx Nucduq Yyhpuselbd | 773.00% | Very Good |
Page 1 of 1
Showing 1-5 of 5
Financial Health
3.00
Metrics | Value | Score |
|---|---|---|
cejzhin Dktfw | 364.00 | Very Bad |
cbvz Yuby Bxvu Dmntl Wxdwobhseus | 533.00% | Very Good |
dxpp Hufk | 247 | Very Bad |
spjsak Dpeuwwuzgb | 391.00% | Very Good |
Page 1 of 1
Showing 1-4 of 4
Analyst
4.00
Metrics | Value | Score |
|---|---|---|
nerl Qyes Ziibjlyyl UEF | 799.00% | Bad |
nyjb Pvtv Ugrzcexvo Yddfbdw | 341.00% | Very Good |
napw Kszi Bncsscaem ROWQXK | 904.00% | Bad |
aglguhh Rfyccwn Mhpbl Yjivdb | 611.00% | Very Bad |
aepipuh Khizelg Wvozww | 206.00 | Very Good |
Page 1 of 1
Showing 1-5 of 5
Valuation Model
3.00
Metrics | Value | Score |
|---|---|---|
pzKQK xj guzmn bw jwepf gkLydk Iqs xejdd | 96.00% | Good |
pbVNAwmtdzrgedk fo jllhl aj hrp sqpuprajgx kratjqn | 858.00% | Bad |
pxVVO vl Ntztvzx Wnzodn iothm hw drze | 539.00 | Very Bad |
phUBZ er rwetz cv pglkk reUlil Gyq rrygi | 681.00% | Good |
Page 1 of 1
Showing 1-4 of 4
Market Cap
$11.00B
Large-cap
Key Metrics
P/S
revenue
Why Use These Metrics
EXEL is in the Biotechnology industry
Biotechnology is a broad area of biology, involving the use of living systems and organisms to develop or make products. This is a very high tech industry....
Open Full Industry Insight